BBSRC Portfolio Analyser
Award details
Industrial biocatalysts by design: rational re-engineering of flavocytochrome p450 BM3 for chiral chemical synthesis
Reference
E20186
Principal Investigator / Supervisor
Professor Gordon Roberts
Co-Investigators /
Co-Supervisors
Professor Paul Cullis
,
Professor Andrew Munro
,
Dr Andrew Westlake
Institution
University of Leicester
Department
Biochemistry
Funding type
Research
Value (£)
243,929
Status
Completed
Type
Research Grant
Start date
01/01/2004
End date
31/12/2006
Duration
36 months
Abstract
We will use rational and localised random mutagenesis of the mono-oxygenase P450 BM3 to generate catalysts that hydroxylate/epoxidate key molecules, providing chiral intermediates for complex organic synthesis. Our previous work shows the feasibility of re-designing BM3 to alter its substrate specificity and the regio- and stereoselectivity of oxidation. Molecular biology, enzymology and structural biology will be combined to engineer biotechnologically-exploitable variants. Specific targets to be addressed include 6,8-dihydoxyoctanoate (lipoate synthesis); indan-1,2-diol (protease inhibitors), 3,4-epoxybutanoate (carnitine synthesis) and styrene epoxides for synthesis of, e.g., beta-adrenergic agonists.
Summary
unavailable
Committee
Closed Committee - Engineering & Biological Systems (EBS)
Research Topics
X – not assigned to a current Research Topic
Research Priority
X – Research Priority information not available
Research Initiative
X - not in an Initiative
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search